These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35671049)

  • 41. Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy.
    van Steensel L; Paridaens D; Schrijver B; Dingjan GM; van Daele PL; van Hagen PM; van den Bosch WA; Drexhage HA; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3091-8. PubMed ID: 19234339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
    Dik WA; Virakul S; van Steensel L
    Exp Eye Res; 2016 Jan; 142():83-91. PubMed ID: 26675405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Graves' immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured Graves' orbital fibroblasts.
    Heufelder AE; Bahn RS
    Eur J Clin Invest; 1992 Aug; 22(8):529-37. PubMed ID: 1358619
    [TBL] [Abstract][Full Text] [Related]  

  • 44. EZH2 as a major histone methyltransferase in PDGF-BB-activated orbital fibroblast in the pathogenesis of Graves' ophthalmopathy.
    Visamol S; Palaga T; Saonanon P; Pruksakorn V; Hirankarn N; van Hagen PM; Dik WA; Virakul S
    Sci Rep; 2024 Apr; 14(1):7947. PubMed ID: 38575707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic Effect of Curcumin, a Plant Polyphenol Extracted From Curcuma longae, in Fibroblasts From Patients With Graves' Orbitopathy.
    Lee JS; Kim J; Lee EJ; Yoon JS
    Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4129-4140. PubMed ID: 31593984
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
    van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
    Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Search of reference biomarkers reflecting orbital tissue remodeling in the course of Graves' orbitopathy.
    Pawlowski P; Poplawska I; Mysliwiec J; Dik WA; Eckstein A; Berchner-Pfannschmidt U; Milewski R; Lawicki S; Dzieciol-Anikiej Z; Rejdak R; Reszec J
    Folia Histochem Cytobiol; 2020; 58(1):37-45. PubMed ID: 32176314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tea Polyphenols Reduce Inflammation of Orbital Fibroblasts in Graves' Ophthalmopathy via the NF-κB/NLRP3 Pathway.
    Liu W; Ma C; Li HY; Yuan SS; Li KJ
    Curr Med Sci; 2023 Feb; 43(1):123-129. PubMed ID: 36821039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of miR-146a in the Regulation of Inflammation in an In Vitro Model of Graves' Orbitopathy.
    Jang SY; Chae MK; Lee JH; Lee EJ; Yoon JS
    Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4027-34. PubMed ID: 27494344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Astragaloside IV attenuates orbital inflammation in Graves' orbitopathy through suppression of autophagy.
    Li H; Zhang Y; Min J; Gao L; Zhang R; Yang Y
    Inflamm Res; 2018 Feb; 67(2):117-127. PubMed ID: 29127443
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GSDMD mediated pyroptosis induced inflammation of Graves' orbitopathy via the NF-κB/ AIM2/ Caspase-1 pathway.
    Sha X; Ye H; Wang X; Xu Z; Sun A; Xiao W; Zhang T; Yang S; Yang H
    Exp Eye Res; 2024 Mar; 240():109812. PubMed ID: 38342335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. JNK and p38 Inhibitors Prevent Transforming Growth Factor-β1-Induced Myofibroblast Transdifferentiation in Human Graves' Orbital Fibroblasts.
    Hou TY; Wu SB; Kau HC; Tsai CC
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799469
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy.
    Rotondo Dottore G; Leo M; Casini G; Latrofa F; Cestari L; Sellari-Franceschini S; Nardi M; Vitti P; Marcocci C; Marinò M
    Thyroid; 2017 Feb; 27(2):271-278. PubMed ID: 27824294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of Orbital Fibrosis and Adipogenesis by Pathogenic Th17 Cells in Graves Orbitopathy.
    Fang S; Huang Y; Zhong S; Li Y; Zhang Y; Li Y; Sun J; Liu X; Wang Y; Zhang S; Xu T; Sun X; Gu P; Li D; Zhou H; Li B; Fan X
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4273-4283. PubMed ID: 28938397
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts.
    Diao J; Chen X; Mou P; Ma X; Wei R
    Invest Ophthalmol Vis Sci; 2022 Sep; 63(10):6. PubMed ID: 36094643
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simvastatin and ROCK Inhibitor Y-27632 Inhibit Myofibroblast Differentiation of Graves' Ophthalmopathy-Derived Orbital Fibroblasts
    Wei YH; Liao SL; Wang SH; Wang CC; Yang CH
    Front Endocrinol (Lausanne); 2020; 11():607968. PubMed ID: 33597925
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunophenotype of Lacrimal Glands in Graves Orbitopathy: Implications for the Pathogenesis of Th1 and Th17 Immunity.
    Huang Y; Wu Y; Zhang S; Lu Y; Wang Y; Liu X; Zhong S; Wang Y; Li Y; Sun J; Fang S; Zhou H
    Thyroid; 2022 Aug; 32(8):949-961. PubMed ID: 35469435
    [No Abstract]   [Full Text] [Related]  

  • 58. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients.
    Wakelkamp IM; Bakker O; Baldeschi L; Wiersinga WM; Prummel MF
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):280-7. PubMed ID: 12608932
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL-17A Exacerbates Fibrosis by Promoting the Proinflammatory and Profibrotic Function of Orbital Fibroblasts in TAO.
    Fang S; Huang Y; Wang S; Zhang Y; Luo X; Liu L; Zhong S; Liu X; Li D; Liang R; Miranda P; Gu P; Zhou H; Fan X; Li B
    J Clin Endocrinol Metab; 2016 Aug; 101(8):2955-65. PubMed ID: 27224264
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
    Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
    World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.